DERMAFUSONE 20 mg/1 mg/g, cream tube, 30 g
Active ingredients: Fusidic acid, Anhydrous fusidic acid, Betamethasone, Betamethasone valerate
Commercialized according to BDPMDispensing in France: Prescription only
Creamtube, 30 gcutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DERMAFUSONE 20 mg/1 mg/g, crème
- Pharmaceutical form
- crème
- Route of administration
- cutanée
- Presentation description
- 1 tube(s) aluminium de 30 g
- Marketing authorisation holder
- LABORATOIRES BAILLEUL (LUXEMBOURG)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 26 Aug 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63101233CIP73015695CIP133400930156957Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BÉTAMÉTHASONEcrème | 1 mg · 1 g de crème | FT |
| ACIDE FUSIDIQUEcrème | — | SA |
| VALÉRATE DE BÉTAMÉTHASONEcrème | 1,214 mg · 1 g de crème | SA |
| ACIDE FUSIDIQUE ANHYDREcrème | 20 mg · 1 g de crème | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.